Cargando…
SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways
With global expansion of the COVID-19 pandemic and the emergence of new variants, extensive efforts have been made to develop highly effective antiviral drugs and vaccines against SARS-CoV-2. The interactions of coronaviruses with host antiviral interferon pathways ultimately determine successful vi...
Autores principales: | Oh, Soo-Jin, Shin, Ok Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Microbiological Society of Korea
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817151/ https://www.ncbi.nlm.nih.gov/pubmed/35122601 http://dx.doi.org/10.1007/s12275-022-1525-1 |
Ejemplares similares
-
Immune evasion of SARS-CoV-2 from interferon antiviral system
por: Min, Yuan-Qin, et al.
Publicado: (2021) -
Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options
por: Znaidia, Mariem, et al.
Publicado: (2022) -
Evasion of Type I Interferon by SARS-CoV-2
por: Xia, Hongjie, et al.
Publicado: (2020) -
Mechanisms of Antiviral Immune Evasion of SARS-CoV-2
por: Beyer, Daniel K., et al.
Publicado: (2022) -
SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response
por: Oh, Soo Jin, et al.
Publicado: (2021)